Basic Materials / Specialty ChemicalsNSE
$936.50
+3.35 (+0.36%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-619.3M · quality 50.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$29.4B
P/E
65.6x
↑EV/EBITDA
8.1x
↓ROE
1.1%
↑Gross Margin
37.1%
↑Debt/Equity
0.22
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-2.5%
FCF CAGR
-37.1%
FCF margin
1.9%
FCF / Net income
2.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $70.86B · net income $449.5M · FCF $1.32B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $70.86B | $70.86B | $68.85B | $62.94B | $76.40B |
| Net Income | $449.5M | $449.5M | $2.09B | $378.3M | $3.48B |
| EBITDA | $4.37B | $4.37B | $7.91B | $4.22B | $10.39B |
| EPS | 14.32 | 14.32 | 66.64 | 12.05 | 110.97 |
| Gross Margin | 37.1% | 37.1% | 36.9% | 23.4% | 27.4% |
| Operating Margin | 14.5% | 14.5% | 17.2% | 2.4% | 8.6% |
| Net Margin | 0.6% | 0.6% | 3.0% | 0.6% | 4.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.22 | 0.22 | 0.23 | 0.21 | 0.23 |
| Current Ratio | 2.59 | 2.59 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.32B | $1.32B | $-646.9M | $-619.3M | $5.29B |
| Returns | |||||
| ROE | 1.1% | 1.1% | 5.6% | 1.1% | 10.0% |
| Valuation | |||||
| P/E | 65.58 | 65.58 | 18.03 | 75.25 | 11.29 |
| EV/EBITDA | 8.13 | 8.13 | 5.37 | 7.42 | 3.63 |
| P/B | 0.69 | 0.69 | 1.00 | 0.81 | 1.13 |
| Growth & Yield | |||||
| Revenue Growth | 2.9% | 2.9% | 9.4% | -17.6% | — |
| EPS Growth | -78.5% | -78.5% | 453.0% | -89.1% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
79.7%
EPS terminal req.
$83.10
Spread vs growth
-158.2%
5Y implied EPS CAGR
47.7%
EPS terminal req.
$100.55
Spread vs growth
-126.2%
10Y implied EPS CAGR
27.5%
EPS terminal req.
$161.94
Spread vs growth
-106.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-31.3%
Start / end P/E
20.7x → 65.4x
EPS bridge
66.64 → 14.32
Residual
-170.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.